Although breast cancer cells also express chemokine receptors including CCR5, CCR7 and CXCR4 that enhance tumor cell invasiveness and metastasis [44], it is unlikely that a single treatment with chemokine antagonist can directly induce tumor cell death. The gene discussed is CXCR4; the disease is neoplasm.